DE60226953D1 - Linderung von akrochordon - Google Patents

Linderung von akrochordon

Info

Publication number
DE60226953D1
DE60226953D1 DE60226953T DE60226953T DE60226953D1 DE 60226953 D1 DE60226953 D1 DE 60226953D1 DE 60226953 T DE60226953 T DE 60226953T DE 60226953 T DE60226953 T DE 60226953T DE 60226953 D1 DE60226953 D1 DE 60226953D1
Authority
DE
Germany
Prior art keywords
acrochordon
pigmentation
reduction
acrochordon removal
removal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60226953T
Other languages
English (en)
Inventor
Mickey Miller
Margaret Ancira
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mickey Joe Miller Ii Us
Mickey Lyon Miller Us
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60226953D1 publication Critical patent/DE60226953D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/22—Peroxides; Oxygen; Ozone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Detergent Compositions (AREA)
DE60226953T 2001-02-09 2002-02-08 Linderung von akrochordon Expired - Lifetime DE60226953D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26797801P 2001-02-09 2001-02-09
PCT/US2002/003530 WO2002064151A1 (en) 2001-02-09 2002-02-08 Acrochordon alleviation

Publications (1)

Publication Number Publication Date
DE60226953D1 true DE60226953D1 (de) 2008-07-17

Family

ID=23020931

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60226953T Expired - Lifetime DE60226953D1 (de) 2001-02-09 2002-02-08 Linderung von akrochordon

Country Status (13)

Country Link
US (1) US7138146B2 (de)
EP (1) EP1365781B1 (de)
JP (1) JP2004518715A (de)
CN (1) CN100508990C (de)
AT (1) ATE397452T1 (de)
BR (1) BR0207163A (de)
CA (1) CA2437823A1 (de)
DE (1) DE60226953D1 (de)
IL (1) IL157321A0 (de)
MX (1) MXPA03007151A (de)
NZ (1) NZ527673A (de)
SG (1) SG167656A1 (de)
WO (1) WO2002064151A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852832B1 (fr) 2003-03-25 2008-06-27 Oreal Composition de coloration pour fibres keratiniques comprenant un acide hydroxycarboxilique ou un sel, composition prete a l'emploi la comprenant, procede de mise en oeuvre et dispositif
US8257780B2 (en) 2003-10-31 2012-09-04 Resource Development L.L.C. Therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders and methods of using
KR20060004399A (ko) * 2004-07-09 2006-01-12 에스케이케미칼주식회사 자기발열체를 이용한 케토프로펜의 경피투여 시스템
WO2006085302A2 (en) * 2005-02-08 2006-08-17 Bmz Diagnosis (2004) Ltd. Composition for treatment of skin disorders
FR2947452B1 (fr) * 2009-07-01 2012-04-20 Fabre Pierre Dermo Cosmetique L-serine et/ou l-asparagine et/ou l-valine pour prevenir et/ou au traiter des reactions inflammatoires de la peau.
JP5431501B2 (ja) * 2010-01-13 2014-03-05 株式会社東芝 画像処理装置、及びその方法
WO2012177799A1 (en) * 2011-06-20 2012-12-27 Atheronova Operations, Inc. Subcutaneous fat reduction
EP3134061B1 (de) * 2014-04-21 2020-10-07 Aclaris Therapeutics, Inc. Peroxidformulierungen sowie verfahren und applikatoren zur verwendung damit
JP6543091B2 (ja) * 2014-06-03 2019-07-10 御木本製薬株式会社 Ｐｍｅｌ１７遺伝子発現抑制剤
CN105557691B (zh) * 2015-12-31 2018-07-20 中国检验检疫科学研究院 一种枣实蝇引诱剂及其应用
CN108459157B (zh) * 2018-01-11 2020-11-27 中国药科大学 一种预测伊立替康化疗毒性生物标志物的组合物
CN110898076A (zh) * 2019-12-12 2020-03-24 刘贤贤 一种去除角质的药物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3954974A (en) 1972-06-09 1976-05-04 Paul Herzog Disinfectant for the surface of human body parts containing hydrogen peroxide
US4018802A (en) 1975-04-09 1977-04-19 Merck & Co., Inc. 9-Thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins and processes
US4128564A (en) 1976-03-22 1978-12-05 Merck & Co., Inc. 9-Thia- and oxothia- and 9-dioxothia-11,12-seco-prostaglandins
US4485091A (en) 1980-07-15 1984-11-27 Quinoderm Limited Dermatological compositions
US4438102A (en) 1982-08-10 1984-03-20 Ciro's Touch, Ltd. Method of promoting tissue growth
LU85789A1 (fr) * 1985-02-26 1986-09-02 Oreal Utilisation dans les domaines therapeutique et cosmetique d'une solution anhydre de peroxyde d'hydrogene
US5380764A (en) * 1989-06-08 1995-01-10 Herzog; Paul Composition of vitamin A, glucose and hydrogen peroxide for cosmetic or pharmaceutical use
GB9007762D0 (en) 1990-04-05 1990-06-06 Beecham Group Plc Novel compounds
JPH04159229A (ja) * 1990-09-14 1992-06-02 Senju Pharmaceut Co Ltd 真珠腫治療剤
JPH06206825A (ja) 1992-12-11 1994-07-26 Nippon Rooshiyon Kk 白癬菌、湿疹等による皮膚病の治療剤及び 皮膚殺菌活性化剤
GB2285218A (en) 1993-12-17 1995-07-05 William Elwyn Roberts An aid to recovery from disease caused by bacteria fungi viruses and malignant cells
US5594015A (en) 1994-06-22 1997-01-14 Regents Of The University Of California Thiazolidine derivatives for the treatment of psoriasis
US5736582A (en) 1996-10-10 1998-04-07 Devillez; Richard L. Method and composition for controlled delivery of nascent oxygen from hydrogen peroxide source for skin treatment
US5958984A (en) * 1996-10-10 1999-09-28 Devillez; Richard L. Method and composition for skin treatment
US6028104A (en) 1997-01-30 2000-02-22 Ecolab Inc. Use of peroxygen compounds in the control of hairy wart disease
US6146640A (en) 1998-08-31 2000-11-14 Dyke; John Paul Immune system catalyst

Also Published As

Publication number Publication date
WO2002064151A1 (en) 2002-08-22
NZ527673A (en) 2005-03-24
EP1365781B1 (de) 2008-06-04
BR0207163A (pt) 2004-06-29
IL157321A0 (en) 2004-02-19
CN1501804A (zh) 2004-06-02
CA2437823A1 (en) 2002-08-22
EP1365781A1 (de) 2003-12-03
US7138146B2 (en) 2006-11-21
MXPA03007151A (es) 2004-10-15
CN100508990C (zh) 2009-07-08
US20030008018A1 (en) 2003-01-09
ATE397452T1 (de) 2008-06-15
SG167656A1 (en) 2011-01-28
EP1365781A4 (de) 2005-01-12
JP2004518715A (ja) 2004-06-24

Similar Documents

Publication Publication Date Title
DE69923671D1 (de) Verwendung von kannabidiol als entzündunghemmende mittel
DE60226953D1 (de) Linderung von akrochordon
DE60107065D1 (de) Behandlung des kongestiven herzversagens durch vorbehandeltes autologes blut
NO20041598L (no) Fremgangsmater for behandling eller profylakse av vaskulaer betennelse ved anvendelse av sterolabsorpsjonsinhibitor(er)
EP1401479A4 (de) Nachweis und therapie von empfindlichem plaque mit photodynamischen verbindungen
ATE328599T1 (de) Antitumorale mittel
ATE505488T1 (de) Modulator von coagulationskaskaden und fibrinolytischen kaskaden
WO2002034072A3 (en) Synergistic antioxidant combination of delta tocols and polyphenols
EA200800755A1 (ru) Ikk ингибиторы, предназначенные для лечения эндометриоза
CY1107649T1 (el) Συνδυασμος ο οποιος περιεχει ενα αντιφολικο αλας και παραγοντα ελαττωσης μεθυλομηλονικου οξεος
NO20056073L (no) Sammensetninger og fremgangsmater til behandling av alvorlig akutt respitatorisk syndrom (SARS)
EA200101089A1 (ru) Новый способ лечения
BR0312149A (pt) Métodos para lisar um coágulo sanguìneo, para degradar proteoliticamente um coágulo sanguìneo, para restaurar a desobstrução em um dispositivo de acesso vascular permanente e para restaurar a função a um dispositico de acesso vascular permanente, e, uso de uma metaloproteinase fibrinolìtica
NO20051681L (no) Lysaldring av hud og aktinskadebehandling
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
IL138290A0 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
WO2003049674A3 (en) Method for treatment of enveloped viruses using jojoba oil esters
ATE493113T1 (de) Topische zubereitung zur behandlung von zehennagelpilz
EA200100543A1 (ru) Способ предотвращения развития атеросклероза у млекопитающих
DE60109594D1 (de) R-eliprodil zur behandlung von glaucoma
ATE254915T1 (de) Kombination von acetyldinalin und docetaxel
BR0312402A (pt) Utilização de inibidores seletivos de ciclooxigenase-2 e agentes trombolìticos para o tratamento ou prevenção de um episódio vaso-oclusivo
PA8500101A1 (es) Composiciones y métodos para tratar condiciones alérgicas e inflamatorias con tos
UA36309A (uk) Спосіб лікування виразкової хвороби, ускладненої перфорацією або кровотечею, у людей похилого віку
UA37607A (uk) Спосіб лікування кровотечі з варикозно-розширених вен стравоходу

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: DEHMEL & BETTENHAUSEN PATENT- UND RECHTSANWAELTE,

8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: DERZEIT KEIN VERTRETER BESTELLT

R073 Re-establishment requested

Ref document number: 1365781

Country of ref document: EP

R074 Re-establishment allowed

Ref document number: 1365781

Country of ref document: EP

R081 Change of applicant/patentee

Ref document number: 1365781

Country of ref document: EP

Owner name: MICKEY LYON MILLER, US

Free format text: FORMER OWNER: MICKEY MILLER, PARADISE VALLEY, US

Effective date: 20120925

Ref document number: 1365781

Country of ref document: EP

Owner name: MICKEY JOE MILLER II, US

Free format text: FORMER OWNER: MICKEY MILLER, PARADISE VALLEY, US

Effective date: 20120925

R074 Re-establishment allowed

Ref document number: 1365781

Country of ref document: EP

Effective date: 20121016